Xconomy | Boston - Business + Technology in the Exponential Economy

Boston Scientific Wins FDA Approval of Stent for Smaller Blood Vessels

Boston Scientific said today it has won clearance from the FDA to market the Taxus Express2 Atom Stent System. The new device, which props open clogged heart arteries, emits a small dose of a chemotherapy drug designed to minimize scarring around the implant. It is the only device approved for vessels as small as 2.25 millimeters in diameter, the Natick, MA-based company (NYSE: BSX) said in a statement. The company plans to start selling the device immediately.

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.

Comments | Reprints | Share: